Arteriosclerosis, Thrombosis, Vascular Biology
Science NewsView All Science News
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with und...
06/29/2020 | The investigation of noncoding RNAs has exponentially expanded, leading to new knowledge about the function of RNA molecules and insight ...
06/24/2020 | ATVB July 2020 Editor's Pick and Featured Article
Vascular Discovery: From
Genes to Medicine 2020
May 5–7, 2020
Virtual Event
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Kerry-Anne Rye, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Peripheral Vascular Disease (PVD)
The Council on Peripheral Vascular Disease (PVD) is a vibrant, interdisciplinary council whose members are focused on improving the care of patients with vascular diseases through advancing science, education, advocacy, and improved healthcare delivery. To achieve our goals within the American Heart Association we need to continue to grow our membership and foster their active involvement in all of our educational programs and scientific initiatives. This means we need you!
Naomi Hamburg, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease
Podcast series on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D) with cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making — among other topics. Listen today and improve your patient’s outcomes!
Podcast Series: HIV and CVD
Introducing a Podcast Series on HIV and CVD — this six-part series will cover life expectancy in the modern HAART era, HIV and atherosclerotic CVD, HIV screening and prevention, and HIV and heart failure.